Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pacira BioSciences, Inc. - Common Stock
(NQ:
PCRX
)
22.69
-0.57 (-2.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pacira BioSciences, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
April 19, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
April 03, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Analyst Expectations for Pacira BioSciences's Future
↗
February 28, 2023
Via
Benzinga
Earnings Preview For Pacira BioSciences
↗
February 27, 2023
Via
Benzinga
Where Pacira BioSciences Stands With Analysts
↗
January 31, 2023
Via
Benzinga
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
March 29, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
March 27, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
March 22, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences's Return On Capital Employed Insights
↗
November 23, 2022
Via
Benzinga
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
March 08, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
February 28, 2023
From
Pacira BioSciences
Via
GlobeNewswire
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
February 23, 2023
Multi-year agreement will make Pacira’s medical device ioveraº the Official Non-Opioid Pain Management Partner of the LPGA
From
Pacira BioSciences
Via
GlobeNewswire
Earnings Scheduled For February 28, 2023
↗
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Pacira to Report 2022 Financial Results on Tuesday February 28, 2023
February 21, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
↗
January 23, 2023
On Monday, 12 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
January 10, 2023
Tuesday's session saw 16 companies set new 52-week lows.
Via
Benzinga
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
January 05, 2023
EXPAREL average daily sales 104% of the prior year for the fourth quarter and 107% of the prior year for the month of December
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Pacira BioSciences
Via
GlobeNewswire
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
↗
December 13, 2022
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
December 13, 2022
On Tuesday, 49 companies hit new 52-week lows.
Via
Benzinga
Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022
December 13, 2022
EXPAREL sales were 99 percent and unit volumes were 104 percent of November 2021
From
Pacira BioSciences
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
↗
November 16, 2022
On Wednesday, 70 companies set new 52-week lows.
Via
Benzinga
Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022
November 14, 2022
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Present at Two Healthcare Conferences in November
November 08, 2022
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences: Q3 Earnings Insights
↗
November 03, 2022
Pacira BioSciences (NASDAQ:PCRX) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Pacira BioSciences Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022
October 20, 2022
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million
October 13, 2022
-- EXPAREL average daily sales 109% of the prior year for the third quarter and 113% of the prior year for the month of September --
From
Pacira BioSciences
Via
GlobeNewswire
Pacira Pharmaceuticals Stock Shows Rising Relative Strength
↗
October 07, 2022
On Friday, Pacira Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 69 to 73.
Via
Investor's Business Daily
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
